About us
TimeTeller® combines research results on molecular interactions of the internal biological clock with clock-controlled genes and their impact in diseases. TimeTeller® is a spin-off of the Charité Universitätsmedizin Berlin and builds upon the research of the Circadian Medicine and Systems Biology research group lead by Angela Relógio.
TimeTeller® as a project was initially funded by „Inventors for Health“ (I4H)-program by the Stiftung Charité and later by the Digital Health Accelerator (DHA) from the Berlin Institute of Health (BIH). Within these programs a medical device was developed. Benjamin Dose joined the TimeTeller® project at this stage to support the team amongst others in regulatory matters. In March 2023 TimeTeller® was founded as a GmbH by Angela Relógio, the Ascenion GmbH (the technology transfer partner of Charité) and Benjamin Dose.
At TimeTeller®, our goal is to empower individuals and healthcare professionals with knowledge and tools to optimize health and prevent diseases through understanding and applying the power of circadian rhythms.
We aim to play a crucial role in the field of pharmacological research and drug development by using the knowledge of circadian rhythms to optimize drug efficacy and diminish toxicity. By working with scientists of different research fields and pharmaceutical companies, we want to integrate circadian rhythm-based interventions into drug development processes, ultimately leading to more effective treatments for a variety of diseases.
Our ultimate goal is to make circadian rhythm-based interventions an integral part of healthcare and enable individuals to live healthier, and more enjoyable lives.
- Angela Relógio
- CEO & Co-Founder
Angela Relógio
Prof. Dr. Angela Relógio, CEO and founder of TimeTeller® GmbH, has over a decade of experience leading research groups. With a PhD in molecular biology and an engineering background, she investigates disease-driving mechanisms using an interdisciplinary approach. She is a professor for systems medicine at the Medical School Hamburg and has won several scientific awards, authored numerous publications, and is passionate about translating her research into practical solutions for patients. Her goal is to bridge the gap between research and industry, driving TimeTeller's mission to provide circadian rhythm-based interventions to empower individuals and healthcare professionals.
- Benjamin Dose
- Project Manager & Co-Founder
Benjamin Dose
Dr. Benjamin Dose is Co-founder and project manager at TimeTeller and adds his expertise gained through his PhD in Biochemistry and regulatory consulting to the team. He has been a part of the team since 2021 and was a founding member of TimeTeller in 2023. Benjamin is convinced of the use of research to improve health systems and is committed to TimeTeller's mission of using circadian rhythms to optimise health and prevent disease.
- Deeksha Malhan
- R&D Bioinformatics and AI
Deeksha Malhan
Dr. Deeksha Malhan, research computational expert at TimeTeller, holds a Master’s in Bioinformatics and a PhD in Medicine. She specializes in high-throughput data analysis, biomarker discovery, and applying AI models in biomedical research. Since joining in 2021, Deeksha has used her interdisciplinary expertise to explore circadian rhythm-based approaches that improve health outcomes. Passionate about translating complex data into actionable healthcare solutions, she advances efforts to bridge the gap between bioinformatics and clinical applications.
- Oliver Zimmer
- R&D Pharmacokinetic Modelling
Oliver Zimmer
Dr. Oliver Zimmer joined TimeTeller in 2024, bringing a wealth of expertise in pharmaceutics, with a PhD specializing in Physiologically Based Pharmacokinetic (PBPK) modelling. He plays a key role in translational research projects, focusing on transforming scientific discoveries into real-world solutions. Passionate about harnessing knowledge of the circadian rhythm, Oliver is driven by the potential to enhance health, fitness, and well-being through innovative applications at TimeTeller.
- Müge Yalcin
- Quality Management
Müge Yalcin
Dr. Müge Yalcin is the Quality Manager at TimeTeller GmbH, leveraging her expertise in bioinformatics, clinical study management, and regulatory processes. With a PhD in Integrative Oncology and experience in the pharmaceutical industry, she oversees the development and monitoring of quality management systems. Müge also contributes to research, refining quality metrics and supporting clinical studies to enhance TimeTeller’s digital tools aimed at circadian rhythm-based health interventions and disease prevention.
Advisory Board
- Ilona Renken- Olthoff
Ilona Renken-Olthoff is CEO of the MSH Medical School Hamburg and has a strong national and international network in healthcare. She has successfully founded and established institutions such as MSH Medical School Hamburg, MSB Medical School Berlin, and HMU Health and Medical University Potsdam and Erfurt. Her leadership in higher education, particularly in health sciences, reflects her commitment to adapting medical training to meet evolving healthcare needs. With a proven ability to scale successful institutions, she brings invaluable expertise to TimeTeller. Her deep understanding of the healthcare landscape will guide TimeTeller’s growth, ensuring its solutions are both clinically relevant and commercially viable.
- Elena Ioana Braicu
Elena Ioana Braicu is a Professor of Translational Gynecologic Oncology and leads the translational research efforts in this field at the Charité Universitätsmedizin Berlin. She also heads the clinical trial unit for gynecologic oncology, overseeing critical studies aimed at improving patient outcomes. In addition, she manages the Ovarian Cancer Tumour Bank, a vital resource for cancer research and treatment innovation. With extensive experience in clinical trials and translational research, her expertise is instrumental in bridging research and patient care. Elena's deep understanding of gynecologic oncology will help guide TimeTeller’s clinical applications, ensuring they are aligned with cutting-edge oncology practices. Her guidance strengthens the startup’s commitment to improving cancer treatment outcomes.
- Francis Lévi
Francis Lévi is Professor of biomedicine and oncology, and a pioneering oncologist known for his groundbreaking work in cancer chronotherapy. His research revealed that drug efficacy and tolerability vary significantly based on the time of administration, leading to the creation of programmable drug delivery pumps aligned with circadian rhythms. His work has shown the circadian time dependency of over 20 anticancer agents, helping to optimize chemotherapy timing for better patient outcomes. Lévi also established several key research units, including the clinical cancer chronotherapy unit at Paul Brousse Hospital in Paris. His expertise in circadian biology and cancer treatment will be instrumental in advancing TimeTeller’s mission to personalize chronotherapy for cancer patients.
- Andrew Davies
Andrew Davies is Professor of Palliative Medicine at Trinity College Dublin, University College Dublin, and Our Lady's Hospice in Dublin. His clinical and research expertise spans supportive care in cancer, palliative care, and end-of-life care. His current research focuses on cancer-related side effects like anorexia, opioid-induced constipation, circadian rhythm disorders, and remote patient monitoring. He has held leadership roles as the Immediate Past President of the Multinational Association of Supportive Care in Cancer and Past President of the Association for Palliative Medicine of Great Britain and Ireland. His extensive experience in patient care and circadian rhythm research will provide valuable insights for TimeTeller’s clinical strategies.
- Dirk Ehle
Dirk Ehle is an experienced senior executive in the healthcare sector, having held prominent leadership roles such as EVP and President of Elanco Animal Health Europe and President of Bayer Animal Health. He has served as a member of Bayer HealthCare's Executive Committee, contributing to strategic decisions across the organization. Dirk's background includes a strong legal foundation, with studies in law at the universities of Freiburg, Aix-en-Provence, Würzburg, and New York. His deep expertise in healthcare, coupled with his leadership experience in multinational corporations, will be key to guiding TimeTeller’s business development. His insights into the global healthcare landscape and corporate strategy will be invaluable to the company’s growth and expansion.